Healthcare Small Cap Stocks
Healthcare, medical devices, and health IT small caps — companies innovating in diagnostics, treatment delivery, and healthcare administration at compelling valuations.
| Ticker | Company | Price | Mkt Cap | P/E | Rev. Growth | Upside |
|---|---|---|---|---|---|---|
| ENSG | Ensign Group | $196.62 -1.74% | $11.43B | 33.7x | 20.2% | 12.1% |
| VIAV | Viavi Solutions | $36.89 +4.5% | $8.54B | — | 36.4% | -16.2% |
| NVST | Envista Holdings | $25.81 -0.35% | $4.24B | 92.2x | 15% | 11.1% |
| MMSI | Merit Medical Systems | $67.70 -0.78% | $4.02B | 31.8x | 10.9% | 50.7% |
| ALHC | Alignment Healthcare | $18.76 +5.1% | $3.83B | — | 44.4% | 35.9% |
| IRTC | iRhythm Technologies | $116.80 -1.2% | $3.77B | — | 27.1% | 81% |
| STVN | Stevanato Group | $13.73 -0.15% | $3.75B | 23.3x | 4.8% | 83.3% |
| TVTX | Travere Therapeutics | $30.44 -3.12% | $2.81B | — | 73.4% | 39.6% |
| LMAT | LeMaitre Vascular | $108.49 -0.24% | $2.47B | 43.1x | 15.7% | 2.5% |
| ADMA | ADMA Biologics | $9.19 +0.88% | $2.19B | 15.3x | 15.9% | 155.7% |
| CLDX | Celldex Therapeutics | $31.06 -0.64% | $2.07B | — | -89.7% | 74.9% |
| AGIO | Agios Pharmaceuticals | $35.20 +2.95% | $2.06B | — | 86.1% | 24.3% |
| ATEC | Alphatec Holdings | $10.83 -3.82% | $1.64B | — | 20.4% | 125.5% |
| OMCL | Omnicell | $34.15 +0.62% | $1.55B | 853.8x | 2.3% | 68.2% |
| TNDM | Tandem Diabetes Care | $18.61 -1.06% | $1.27B | — | 2.7% | 65.3% |
| NVCR | NovoCure | $10.55 -2.68% | $1.2B | — | 8.1% | 147.1% |
| USPH | US Physical Therapy | $73.74 -0.89% | $1.12B | 51.9x | 12.5% | 41% |
| CNMD | Conmed Corporation | $34.79 -2.08% | $1.08B | 23x | 7.9% | 27.1% |
| XNCR | Xencor | $12.81 +2.23% | $939.5M | — | -46.5% | 121.8% |
| INMD | InMode | $13.79 +0.66% | $873.7M | 9.6x | 6.1% | 23.3% |
| HSTM | HealthStream | $20.45 +0.25% | $606.7M | 33.5x | 7.4% | 49.1% |
| EMBC | Embecta Corp | $8.85 +0.68% | $524.1M | 3.8x | -0.3% | 88.3% |
| EOLS | Evolent Health | $4.03 -6.5% | $262.2M | — | 14.4% | 263.9% |
| TMCI | Treace Medical Concepts | $1.45 +2.84% | $93.7M | — | -9% | 193.1% |
| AMWL | Amwell | $5.50 +3.97% | $91M | — | -22.1% | 13.6% |
| CTSO | Cytosorbents Corporation | $0.58 +6.52% | $36.6M | — | 41.6% | 800.5% |
| TELA | Tela Bio | $0.60 +5.01% | $26.7M | — | 18.2% | 276.7% |
Analysis and Context
This sector screener currently shows 27 stocks from the selected industry segment — updated daily. The average P/E ratio is 32.8x. The average revenue growth rate is 12%. Sectors move through cyclical phases strongly correlated with macro factors — interest rates, GDP growth, commodity prices, and regulatory environment all drive sector dynamics. Analysts see an average of 105.9% upside in these sector names. Compare metrics against the sector average to identify relative over- and undervaluations. Sector concentration increases portfolio risk — maintain adequate diversification across industries and business models.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →